Judge tosses claims of Provigil generics conspiracy; Stada eyes more OTC buys in U.K., Eastern Europe;

@FiercePharma: Prime time for reaching smartphone users? When they're waiting on a doc. More | Follow @FiercePharma

@TracyStaton: Here's @JohnCFierce's take on the Vertex VX-809/Kalydeco PhIII, including interview with CEO Jeff Leiden. Story from FierceBiotech | Follow @TracyStaton

@EricPFierce: Government won't let Indian drugmakers dump price capped 'essential drugs' if they control 1% of the market. Article | Follow @EricPFierce

@CarlyHFierce: Alere rethinks BBI IPO. Story via FierceDiagnostics | Follow @CarlyHFierce

> Cephalon, a unit of Teva Pharmaceutical Industries ($TEVA), persuaded a judge to toss out claims that it conspired with generics makers to delay copies of its wakefulness drug Provigil. Report

> Germany's Stada says it's in advanced talks to buy more over-the-counter drugs and other consumer health products in Britain and Eastern Europe. Report

> A California-based company that specializes in skin-patch drugs for osteoporosis plans to raise $65 million in an initial public offering. Report

> India's Dr. Reddy's Laboratories rolled out its version of AbbVie's ($ABBV) thyroid drug Zemplar (paricalcitol) in the U.S. Report

> U.S.-based generics maker Actavis ($ACT) is donating $25,000 to assist people affected by flooding in the northeastern region of Bulgaria, where it operates two plants. Report

> China's vaccine products company Sinovac said it won a reduction on its value-added tax rate to 3% from 6%. Release

> Indian securities regulators said they would closely monitor AstraZeneca's ($AZN) move to delist its Indian unit, on worries that checks on fraudulent and unfair trades were inadequate. Report

Medical Device News

@FierceMedDev: Abbott gets EU go-ahead for implant in aging eyes. More | Follow @FierceMedDev

@StacyALawrence: Study: 3D mammograms improve breast cancer detection. Story | Follow @StacyALawrence

@MichaelGFierce: Sinus drug delivery startup Intersect ENT files for $80 million IPO. News via the Silicon Valley Business Journal | Follow @MichaelGFierce

@EmilyWFierce: Hospital networks leaking data through misconfigured SMB service, leaving devices open to attack. Story from Wired | Follow @EmilyWFierce

> Newly public Inogen gains on FDA clearance for home oxygen device. More

> Medtronic picks exec to lead Covidien integration. Item

> Self-powered cardiac pacemaker a breakthrough for researchers. Story

> Study: 3D mammograms improve breast cancer detection. Article

Biotech News

@FierceBiotech: AbbVie makes its pitch for Shire buyout, U.K. tax gambit. More | Follow @FierceBiotech

@JohnCFierce: Talking to Shanghai-based biotech exec, going to do PhI in Australia because of better rep, faster regulatory decision on IND--says something. | Follow @JohnCFierce

@DamianFierce: J&J biz cards creating a sub-market at #BIO2014. Will trade for a Stoffels rookie card or hologram edition Gorsky. Picture | Follow @DamianFierce

@EmilyMFierce: Diagnostics maker Cepheid partners with AstraZeneca, Glaxo to combat antibiotic resistance. News | Follow @EmilyMFierce

> Affymax, once a promising biotech, is dissolving. Item

> FDA bars Basilea antibiotic from U.S. market, demands new PhIII data. More

> Versant's Inception plants its booming biotech startup model in Montreal. Story

Drug Delivery News

> Intersect ENT files for $80M IPO to support steroid-delivering sinus implants. More

> InVivo Therapeutics to ax hydrogel drug delivery program, cutting jobs. Story

> Self-healing hydrogel and ultrasound combo allows for 'on demand' delivery. Article

> FDA issues guidances on development of nanotechnology products. Report

> Microneedle patch reduces scar tissue in Singapore studies. Item

> Transdemeral delivery patchmaker Zosano to debut on Nasdaq. News

Diagnostics News

> Qiagen wins FDA OK for organ transplant test. More

> Roche lends Dx tech to Ferring for an infertility treatment. Article

> Cepheid partners with AstraZeneca, Glaxo on drug-resistant infections. News

> Definiens bags $20.4M for tissue diagnostics. Report

> Enzo scores $7M in patent battle with PerkinElmer. Item

> Alere rethinks BBI IPO. Story

Pharma Marketing News

> Novo Nordisk can double sales in a decade, deputy CEO says. Item

> Bring out the confetti: 7 of 2013's launches will join Sovaldi, Tecfidera in blockbuster land. Story

> Prime time for reaching smartphone users? When they're waiting on a doc. More

> FDA's social media translation for brand managers: Don't use Twitter. Article

> Can clot-fighters get a boost from the U.K.'s new enthusiasm? Report

> Amarin picks up Pawn Stars host to pitch its struggling fish-oil pill, Vascepa. News

And Finally... The polio virus has been detected in sewage in Brazil; it's the first time the disease has been identified in the country since 1994. Report

Suggested Articles

Saturday, AstraZeneca revealed more of the data that convinced the FDA to green-light Calquence in previously untreated chronic lymphocytic leukemia.

The efficacy between Keytruda and FerGene's nadofaragene firadenovec look comparable in their studies, though Merck has at least one upper hand.

Thursday, the FDA approved the first three generic versions of Gilenya, but they may not hit the market anytime soon due to ongoing litigation.